GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): A phase I trial in melanoma

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Federica Sallusto, Antonio Lanzavecchia · The Journal of Experimental Medicine · 1994 · 5.2K citations · Full text

Life Sciences, Cell Biology, Immunology +17

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Glen Dranoff, Elizabeth M. Jaffee, A Lazenby et al. · Proceedings of the National Academy of Sciences · 1993 · 2.8K citations

Medicine, Immunology, Oncology +17

WHO Handbook for Reporting Results of Cancer Treatment

M K Palmer · British Journal of Cancer · 1982 · 2.2K citations · Full text

Medicine, Oncology, Cancer Control +11

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

Christophe Caux, Colette Dezutter‐Dambuyant, Daniel Schmitt et al. · Nature · 1992 · 1.6K citations

Life Sciences, Cell Biology, Immunology +13

Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 2

Steven A. Rosenberg · JAMA · 1994 · 1.1K citations

Medicine, Immunology, Oncology +11